Science Applications International Corporation
SAIC Technology Information Technology Services
Science Applications International Corporation’s revenue for fiscal 2026 (year ended January 2026) was $7.3 billion, down 2.90% from fiscal 2025.
- Revenue
- +6.27%
- EPS
- −11.4%
- Free cash flow
- +13.9%
- Total debt
- +8.42%
Quarter to July 2026, against a year earlier
Follow SAIC
Alert me
Science Applications International Corporation (SAIC) valuation and DCF model
At $145.52 the price implies free cash flow after share-based pay growing 2.8% a year for ten years.
Free cash flow after share-based pay grew 9.7% a year over the last ten years, 2.0% over the last five. The price asks for less than its ten-year rate. The industry’s median company is priced for 7.2%.
In January 2017 the price assumed 3.9% a year; Science Applications International Corporation went on to grow free cash flow after share-based pay 9.5% a year to FY2026.
- The price needs
- 2.8% a year for ten years
- $145.52
- today’s price
- Its base case
- 9.7% a year for five years, then 5.8%
- $240.60
- 65.3% above today’s price
Base case on its own ten-year record Science Applications International Corporation’s own growth, carried forward
Its assumptions
Powerpack lets you start from a scenario and type over any of them.
How we got there$5.42b 10 years of cash to equity+$7.73b terminal value−$2.36b net debt=$10.79b equity value÷44.85m shares=$240.60 per share
Valuation against its own history
| Multiple | Current | 5Y avg | 10Y avg | vs 10Y avg | Industry median | vs industry | 10Y range |
|---|---|---|---|---|---|---|---|
| P/E | 16.86× | 15.65× | 18.36× | 8% below | 16.12× | 5% above | |
| P/FCF | 9.97× | 11.92× | 13.56× | 27% below | 13.77× | 28% below | |
| P/B | 4.30× | 3.60× | 4.02× | 7% above | 1.73× | 148% above | |
| EV/EBITDA | 11.39× | 10.94× | 12.54× | 9% below | 9.89× | 15% above | |
| EV/Sales | 1.15× | 1.07× | 1.05× | 10% above | 1.34× | 14% below |
SAIC trades at 9.97× P/FCF, against a 10-year average of 13.56× (range 7.78×–20.81×). That is cheaper than 78% of the last 9 year-end readings; re-rating to the average implies $197.99 per share.